|
Princeton
University Invention # 10-2571
Using a novel computation framework,
researchers at Princeton University and the University of California, Riverside,
have identified potent antagonists of the C3a receptor (C3aR). Inhibition of
binding of C3a to C3aR is an excellent target for drug design against autoimmune
and inflammatory diseases involving...
Published: 3/15/2018
|
Inventor(s): Christodoulos Floudas (deceased) See Fotini P. Baba, Ho ki Fung, Meghan Bellows Peterson, Dimitrios Morikis, Chris Kieslich, Li Zhang
Keywords(s):
Category(s): Biotechnology/Pharmaceuticals
|